Quest for new antibiotics gets first major funding from global partnership
A major global partnership aimed at fighting superbugs announced Thursday that it is investing up to $48 million in research projects, including potentially the first new classes of antibiotics in decades, to target the deadliest drug-resistant bacteria. The investments announced by CARB-X include $24 million in immediate funding for 11 companies. The firms can receive up […]
Related:
FDA nominee to recuse himself from decisions on more than 20 health-care companies
Senator to investigate opioid makers’ role in drug crisis
More than two-thirds of cancer mutations are due to random DNA copying errors, study says
Thanks For You Reading The Post
We are very happy for you to come to our site. Our Website Domain name
https://leomedtrends.blogspot.com/.
Newer Posts
Newer Posts
Older Posts
Older Posts
Main Page
Comments